CognitMarket market news, portfolio research, and investor insights

Wells Fargo has designated Annexon, Inc. (ANNX) as its top pick in the biotechnology sector, maintaining an Overweight rating and a $27.00 price target. The firm highlights a compelling setup ahead of a critical Q4 2026 data readout for its ARCHER II trial in generalized myasthenia gravis (GA) [1].

Key points:

• Wells Fargo assigns a 55% probability of success for a positive Month-15 outcome in the ARCHER II trial, projecting a potential 3-4x stock re-rating [1].
• The company's tanruprubart Biologics License Application is on track for Q4 2026 submission [1].
• Annexon ended Q3 2026 with $213M in cash, with management reiterating financial runway into 2028 [1].

Delek US Holdings (DK) shares climbed 4% after Freedom Broker upgraded the independent refiner to Buy from Hold, raising the price target to $88 from $86 [1].

Key drivers cited:

• Strong Q3 Performance: Nearly doubled adjusted net income to $843M ($13.55/share) due to surging crack spreads and full refinery utilization [1].
• Balance Sheet Improvement: Reduced net debt by $506.4M sequentially, leading to a net cash position for the parent entity [1].
• Shareholder Returns: Increased quarterly dividend by 18% to $0.30/share and authorized up to $100M in Q4 share buybacks [1].

The upgrade suggests significant upside potential following a recent 20% pullback, with analysts highlighting durable downside support from a strengthened balance sheet and heightened distributions [1].

China Automotive Systems (CAAS) announced record electric power steering (EPS) unit sales for Q3 2026, with 567,314 units sold, a 40.1% increase year-over-year. The company also approved a new share repurchase program of up to $5 million, with shares to be bought at prices not exceeding $5.50 over the next 12 months [1].

Key points:

• Q3 EPS unit sales up 40.1% YoY.
• Nine-month EPS sales up 32.7% YoY.
• $5M share buyback authorized, representing a significant return to shareholders for the small-cap auto parts supplier.

Quantum computing firm Rigetti Computing (RGTI) shares fell 8.7% after hours after reporting Q3 results that missed analyst expectations and issuing weaker-than-expected full-year 2026 revenue guidance [1].

Key points:

• Q3 Miss: Adjusted loss of $0.06/share vs. $0.05 estimate; Revenue of $1.4M vs. $3.7M consensus, down 28% YoY.
• Weak Guidance: Full-year 2026 revenue guidance of ~$20M, below analyst consensus of $22.9M.
• Context: Comes despite recent CHIPS Act award of up to $100M [1].

Bank of America has downgraded Wix.com (WIX) to Underperform from Buy, cutting its price target to $68 from $75. The downgrade cites:

• AI Competition: Rising threat from AI coding tools like Lovable and Cursor impacting Wix's core website-building business, especially among agency partners.
• Slowing Core Growth: While Base44 platform shows strong growth, BofA estimates core Wix ARR growth could be as low as 3-4%.
• Profitability Concerns: Increased marketing spending is expected to limit profitability, with Q3 adjusted operating income missing estimates.

BofA also lowered 2027 revenue and EBITDA forecasts, anticipating sustained competitive pressures and slower core business expansion [1].

European equities advanced today, with the STOXX 600 up 0.3%, driven by a sustained fall in global crude oil prices. This occurred despite a hotter-than-expected U.S. CPI report, which showed headline inflation at 0.4% MoM (vs. 0.3% expected) and core CPI at 0.3% MoM (vs. 0.2% expected) [1].

Key takeaways:

• Oil Relief: Brent crude fell 3% to below $90/barrel, its lowest since early September, providing a 'deflationary wave' [1].
• Hawkish Fed Bets: U.S. CPI data cemented expectations for a December Fed rate hike, with traders now pricing an 84% probability (up from 74% a week prior) [1].
• Divergent Reaction: European markets largely looked past the hawkish U.S. macro signals, prioritizing energy price relief [1].

OpenAI's enterprise revenue has surpassed consumer revenue, with its LLMs now reportedly rerouting 20% of all Google Search queries. This shift confirms fears of slowing Google search revenue and highlights the growing competitive pressure from AI chatbots. OpenAI has also added 200 million weekly active users in the last two months [1].

InvestingPro's ProPicks AI model maintains GlobalFoundries (GFS) in its 'Tech Titans' strategy, signaling confidence in the specialty foundry. GFS, a key player in essential silicon for automotive, aerospace, and data centers, recently slipped 7.8% during a broader semiconductor pullback. The company benefits from long-term supply agreements and its strategic position in diversifying the global chip supply chain away from advanced node concentration [1].

Federal Reserve Governor Christopher Waller indicated a December rate hike is likely, even if October inflation data is softer. He suggested a 50 basis point increase should be considered if inflation readings come in higher than forecast, emphasizing the need to follow through on market expectations to maintain Fed credibility. Waller stated that delaying promised hikes could lead to an undesirable loosening of monetary policy [1].

Rocket Lab (RKLB) announced Q3 2026 results, posting record revenue of $268M, beating estimates by $10.83M, and a record $3.6B backlog [1] [2]. However, the company missed EPS estimates, reporting a loss of $0.12 per share against an expected loss of $0.07 [1] [2]. Shares initially surged 10.91% before retreating 7.1% in after-hours trading, reflecting mixed investor reaction to strong top-line growth versus higher costs and a wider quarterly loss [1].

Key points:

• Revenue: $268M, up 73% YoY, driven by Space Systems ($214.8M) and Launch Services ($53.1M) [1].
• Gross Margins: Above guidance at 33.6% GAAP and 38.4% non-GAAP [1].
• Q4 2026 Outlook: Revenue guidance of $270M-$290M, above consensus [2].